Login / Signup

IgM Plasma Cell Myeloma.

Haiyan LuLisa DurkinXiaoxian ZhaoMegan O Nakashima
Published in: American journal of clinical pathology (2021)
Distinguishing IgMPCM from other IgM-related disorders requires correlation with clinical, laboratory, and radiologic findings. Exclusion of MYD88 L265P and WHIM-like CXCR4 mutations may be useful to diagnose IgMPCM.
Keyphrases
  • single cell
  • cell therapy
  • toll like receptor
  • multiple myeloma
  • newly diagnosed
  • immune response
  • bone marrow